| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Clin Mol Hepatol.2017;23(1):42-50.   Published online March 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0058
                              Supplementary         Cited By 4
Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
Gaeun Kim, Moon Young Kim, Soon Koo Baik
Clin Mol Hepatol.2017;23(1):34-41.   Published online March 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0059
                                 Cited By 22
Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?
Jin Wook Chung
Clin Mol Hepatol.2017;23(1):31-33.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0102
                                 Cited By 1
Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?
Beom Kyung Kim
Clin Mol Hepatol.2017;23(1):27-30.   Published online March 24, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0101
                                 Cited By 1
The use of immunosuppression in autoimmune hepatitis: A current literature review
Angela Cropley, Martin Weltman
Clin Mol Hepatol.2017;23(1):22-26.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0089
                                 Cited By 9
Anticoagulation in cirrhosis: a new paradigm?
Filippo Leonardi, Nicola De Maria, Erica Villa
Clin Mol Hepatol.2017;23(1):13-21.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0110
                                 Cited By 16
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol.2017;23(1):1-12.   Published online March 9, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0109
                                 Cited By 48
Percutaneous cryoablation for hepatocellular carcinoma
Kyoung Doo Song
Clin Mol Hepatol.2016;22(4):509-515.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0079
                                 Cited By 10
Primary adenosquamous carcinoma of the liver: a case report
Kyung Han Nam, Ji Yeon Kim
Clin Mol Hepatol.2016;22(4):503-508.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0077
                                 Cited By 1
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song
Clin Mol Hepatol.2016;22(4):499-502.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0016
                                 Cited By 10
A case of levocetirizine-induced liver injury
Moon Chan Jung, Ja Kyung Kim, Jae Yeon Cho, Jae Won Song, Bohyun Lee, Ji Won Park, Jinwon Seo, Sung Eun Kim
Clin Mol Hepatol.2016;22(4):495-498.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0023
                                 Cited By 3
Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach
Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2016;22(4):487-494.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0050
                                 Cited By 4
Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol.2016;22(4):477-486.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0048
                                 Cited By 7
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding
Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam
Clin Mol Hepatol.2016;22(4):466-476.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0063
                                 Cited By 2
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                                 Cited By 3
Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Clin Mol Hepatol.2016;22(4):450-457.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0036
                                 Cited By 3
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                                 Cited By 5
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
Management of direct antiviral agent failures
María Buti, Rafael Esteban
Clin Mol Hepatol.2016;22(4):432-438.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0107
                                 Cited By 17
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol.2016;22(4):423-431.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0069
                                 Cited By 26
Acute kidney injury in liver cirrhosis: new definition and application
Florence Wong
Clin Mol Hepatol.2016;22(4):415-422.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0056
                                 Cited By 19
What we need to know when performing and interpreting US elastography
So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
Clin Mol Hepatol.2016;22(3):406-414.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0106
                                 Cited By 19
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
Kyoung-Bun Lee
Clin Mol Hepatol.2016;22(3):400-405.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0105
                                 Cited By 5
A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song
Clin Mol Hepatol.2016;22(3):396-399.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0039
                                 Cited By 5
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0050
                                 Cited By 1
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol.2016;22(3):382-389.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0047
                                 Cited By 4
Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim
Clin Mol Hepatol.2016;22(3):372-381.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0032
                                 Cited By 2
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Clin Mol Hepatol.2016;22(3):366-371.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0022
                              
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2016;22(3):359-365.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0033
                                 Cited By 3
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 1409
TOTAL : 250413